 NANPING, China, Oct. 25, 2019 PRNewswire -- Happiness Biotech Group Limited the Company, an innovative China-based nutraceutical and dietary supplements producer, announced today the pricing of a U.S. underwritten initial public offering Offering of 2,000,000 ordinary shares at a price to the public of 5.50 per share. The Company expects to receive aggregate gross proceeds of 11 million from this Offering, before deducting underwriting discounts and other related expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 300,000 ordinary shares at the public offering price, less underwriting discounts. 